StockData
Lexeo Therapeutics, Inc. logo

Lexeo Therapeutics, Inc. (LXEO) stock

LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$2.85−0.38 (-11.61%)

Close on Nov 17, 2026Market cap $234.24MP/E –Yield –

Lexeo Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Lexeo Therapeutics's price to book ratio was 1.0× on Nov 11, 2026, against 4.5× a year earlier. Over the last 3 years it ranged from 0.8× to 4.5×, with a median of 1.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.0×−3.5
2025Dec 31, 20254.5×+3.0
2024Dec 31, 20241.6×–

More Lexeo Therapeutics figures

See a number that looks wrong?